BiotechTube
Home/Pipeline/Blood Biomarker Panel

Blood Biomarker Panel

Parkinson's disease diagnosis

PreclinicalActive

Key Facts

Indication
Parkinson's disease diagnosis
Phase
Preclinical
Status
Active
Company
Synucure Therapeutics

About Synucure Therapeutics

Synucure develops cysteamine‑based disease‑modifying therapy and blood biomarkers to treat and diagnose Parkinson’s disease.

View full company profile

Therapeutic Areas

NeurodegenerationParkinson's Disease

Other Parkinson's disease diagnosis Drugs

DrugCompanyPhase
iRS-PDBetaSenseDevelopment/Validation